Infliximab for vascular involvement in Behçet's syndrome

Copyright © 2023 Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 253(2023) vom: 01. Aug., Seite 109682
Auteur principal: Hatemi, Gulen (Auteur)
Autres auteurs: Tukek, Nur Beyza, Esatoglu, Sinem Nihal, Ozguler, Yesim, Taflan, Sitki Safa, Uygunoglu, Ugur, Melikoglu, Melike, Ugurlu, Serdal, Fresko, Izzet, Siva, Aksel, Kutlubay, Zekayi, Yurdakul, Sebahattin, Yazici, Hasan, Hamuryudan, Vedat
Format: Article en ligne
Langue:English
Publié: 2023
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Aneurysm Behçet's syndrome Infliximab Thrombosis Tumor necrosis factor inhibitors Vascular B72HH48FLU Immunosuppressive Agents